美国 · 平台与数据 · MarketBeat
ArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at Guggenheim

详细摘要
Guggenheim dropped their price target on ArriVent BioPharma from $30.00 to $28.00 and set a "buy" rating for the company in a research report on Monday.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)




